Topical Collection on Immuno-Oncology

In this topical collection (16 articles)

1. 

   Leading Article

   Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer

   Maxime Chénard-Poirier, Elizabeth C. Smyth Pages 1-10

2. Leading Article

   Engaging Natural Killer T Cells as ‘Universal Helpers’ for Vaccination

   Mary Speir, Ian F. Hermans, Robert Weinkove Pages 1-15

   Download PDF (845KB) View Article

3. 

   Current Opinion

   Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies

   Kevin A. Hay, Cameron J. Turtle Pages 237-245

4. 

   AdisInsight Report

   Daratumumab: First Global Approval

   Kate McKeage Pages 275-281

5. 

   AdisInsight Report

   Elotuzumab: First Global Approval

   Anthony Markham Pages 397-403

6. Review Article

   Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors

   Melinda Mata, Stephen Gottschalk Pages 401-415

   Download PDF (2093KB) View Article

7. 

   Review Article

   Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

   Sarah A. Holstein, Philip L. McCarthy Pages 505-520

8. 

   Leading Article

   The Role of Anti-PD-1/PD-L1 Agents in Melanoma: Progress to Date

   Katy K. Tsai, Adil I. Daud Pages 563-575

9. 

   Review Article

   Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

   Lucia Festino, Gerardo Botti, Paul Lorigan, Giuseppe V. Masucci, Jason D. Hipp… Pages 925-945

10. 

    Review Article

    Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives

    Matthew S. Farina, Kevin T. Lundgren, Joaquim Bellmunt Pages 1077-1089

11. 

    Review Article

    Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma

    Laure Hirsch, Ronan Flippot, Bernard Escudier, Laurence Albiges Pages 1169-1181

12. 

    AdisInsight Report

    Atezolizumab: First Global Approval

    Anthony Markham Pages 1227-1232

13. 

    Adis Drug Evaluation

    Nivolumab: A Review in Advanced Melanoma

    Lesley J. Scott Pages 1413-1424

14. 

    Review Article

    Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma

    Ronan Flippot, Bernard Escudier, Laurence Albiges Pages 1443-1457

15. 

    Review Article

    Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma

    Michael D. Jain, John Kuruvilla Pages 1645-1655

16. Leading Article

    Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies

    Kent Shih, Hendrik-Tobias Arkenau, Jeffrey R. Infante Pages 1993-2013

    Download PDF (721KB) View Article